The role of collectivism, liberty, COVID fatigue, and fatalism in public support for the zero-COVID policy and relaxing restrictions in China

Author:

Wang Xiao

Abstract

Abstract Background China was the last country in the world to relax COVID-19 restrictions. A successful public health policy requires public support. This analysis examined the factors associated with Chinese support for zero-COVID and relaxing COVID-19 restrictions in China. Method Two online surveys were conducted among Chinese participants in mainland China on June 10–13 (N = 460) and December 2, 2022 (N = 450). These two samples were similar based on the participants’ demographics. Results The results revealed that the perceived health consequences of a COVID-19 policy, perceived norms of approving a COVID-19 policy, and hope positively predicted the participants’ support for the COVID-19 policy. The results further showed that collectivism and fatalism positively predicted support for zero-COVID and negatively predicted support for relaxing restrictions. COVID fatigue was negatively associated with support for zero-COVID and positively associated with support for relaxing restrictions. Liberty positively predicted support for relaxing restrictions in June and negatively predicted zero-COVID in December 2023. It did not positively or negatively predict support for the policy adopted by the government. Conclusion Collectivism, liberty, COVID fatigue, and fatalistic beliefs are important considerations connected to public support for a COVID-19 policy. The role of liberty was more nuanced and depended on the survey’s time and whether the government adopted the policy.

Funder

College of Liberal Arts, Rochester Institute of Technology

Publisher

Springer Science and Business Media LLC

Reference66 articles.

1. Li Z, Chen Q, Feng L, Rodewald L, Xia Y, Yu H, Li S. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020;396(10243):63–70. https://doi.org/10.1016/S0140-6736(20)31278-2.

2. Liu J, Liu M, Liang W. The dynamic COVID-zero strategy in China. China CDC Wkly. 2022;4(4):74–5. https://doi.org/10.46234/ccdcw2022.015.

3. National Health Commission of the People’s Republic of China. (2022a). 疫情通报 [Pandemic Bulletin] http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml.

4. Centers for Disease Control and Prevention. (2022). Variants of the virus. https://www.cdc.gov/coronavirus/2019-ncov/variants/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvariants%2Fomicron-variant.html.

5. Jackson P, Jalil ZA. (2022). Shanghai lockdown: China eases Covid restrictions after two months. https://www.bbc.com/news/world-asia-china-61647687.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3